Primary |
Contraception |
22.4% |
Product Used For Unknown Indication |
18.7% |
Acne |
8.4% |
Premenstrual Syndrome |
7.5% |
Oral Contraception |
6.8% |
Drug Use For Unknown Indication |
6.4% |
Pain |
4.8% |
Menstruation Irregular |
2.8% |
Depression |
2.8% |
Anxiety |
2.4% |
Asthma |
2.3% |
Migraine |
2.3% |
Polycystic Ovaries |
2.0% |
Menstrual Cycle Management |
1.9% |
Headache |
1.8% |
Gastrooesophageal Reflux Disease |
1.4% |
Hypertension |
1.4% |
Dysmenorrhoea |
1.3% |
Multiple Allergies |
1.3% |
Menorrhagia |
1.3% |
|
Pulmonary Embolism |
18.5% |
Pain |
14.7% |
Deep Vein Thrombosis |
10.3% |
Injury |
7.8% |
Gallbladder Disorder |
6.2% |
Gallbladder Injury |
4.3% |
Cholecystitis Chronic |
4.3% |
Cholelithiasis |
4.1% |
Cholecystectomy |
4.1% |
Anxiety |
4.0% |
Vomiting |
4.0% |
Emotional Distress |
3.5% |
Thrombosis |
3.5% |
Cerebrovascular Accident |
1.8% |
Nausea |
1.7% |
Abdominal Pain |
1.5% |
Thrombophlebitis Superficial |
1.5% |
Pain In Extremity |
1.5% |
Cholecystitis |
1.4% |
General Physical Health Deterioration |
1.4% |
|
Secondary |
Contraception |
19.9% |
Product Used For Unknown Indication |
17.6% |
Acne |
15.7% |
Premenstrual Syndrome |
13.1% |
Drug Use For Unknown Indication |
4.7% |
Oral Contraception |
4.2% |
Pain |
3.3% |
Menstruation Irregular |
2.8% |
Menstrual Cycle Management |
2.7% |
Depression |
2.1% |
Polycystic Ovaries |
1.9% |
Migraine |
1.7% |
Anxiety |
1.7% |
Dysmenorrhoea |
1.6% |
Menorrhagia |
1.6% |
Asthma |
1.5% |
Headache |
1.2% |
Hypertension |
1.0% |
Multiple Allergies |
0.9% |
Gastrooesophageal Reflux Disease |
0.9% |
|
Pain |
20.9% |
Pulmonary Embolism |
12.7% |
Injury |
12.2% |
Deep Vein Thrombosis |
6.6% |
Gallbladder Disorder |
6.3% |
Cholecystitis Chronic |
4.7% |
Cholelithiasis |
4.2% |
Cholecystectomy |
4.2% |
Emotional Distress |
4.1% |
Anxiety |
4.0% |
Thrombosis |
3.8% |
Gallbladder Injury |
3.3% |
Vomiting |
2.6% |
Cholecystitis |
1.7% |
Abdominal Pain Upper |
1.6% |
Abdominal Pain |
1.5% |
Anhedonia |
1.5% |
Cerebrovascular Accident |
1.4% |
Nausea |
1.4% |
General Physical Health Deterioration |
1.4% |
|
Concomitant |
Product Used For Unknown Indication |
19.6% |
Contraception |
17.9% |
Drug Use For Unknown Indication |
10.8% |
Acne |
8.7% |
Depression |
5.8% |
Crohn's Disease |
5.0% |
Rheumatoid Arthritis |
5.0% |
Multiple Sclerosis |
3.5% |
Oral Contraception |
2.7% |
Asthma |
2.5% |
Anxiety |
2.4% |
Migraine |
2.4% |
Insomnia |
2.3% |
Smoking Cessation Therapy |
2.3% |
Pain |
2.0% |
Diabetes Mellitus |
1.6% |
Hepatitis C |
1.5% |
Hypertension |
1.5% |
Relapsing-remitting Multiple Sclerosis |
1.3% |
Attention Deficit/hyperactivity Disorder |
1.3% |
|
Vomiting |
17.6% |
Weight Decreased |
8.2% |
Weight Increased |
7.9% |
Pregnancy |
7.6% |
Urticaria |
6.5% |
Nausea |
5.9% |
Suicidal Ideation |
4.7% |
Rash |
4.4% |
Pain |
4.1% |
Thrombosis |
4.1% |
Headache |
3.5% |
Somnolence |
3.5% |
Unintended Pregnancy |
3.5% |
Abortion Spontaneous |
3.2% |
Drug Exposure During Pregnancy |
2.9% |
Tremor |
2.6% |
Vaginal Haemorrhage |
2.6% |
Metrorrhagia |
2.3% |
Swelling Face |
2.3% |
Wrong Technique In Drug Usage Process |
2.3% |
|
Interacting |
Pneumonia |
25.0% |
Contraception |
21.9% |
Affect Lability |
12.5% |
Depression |
12.5% |
Psychotic Disorder |
6.3% |
Convulsion |
3.1% |
Drug Use For Unknown Indication |
3.1% |
Menstruation Irregular |
3.1% |
Onychomycosis |
3.1% |
Oral Contraception |
3.1% |
Prophylaxis Against Transplant Rejection |
3.1% |
Social Phobia |
3.1% |
|
Pulmonary Embolism |
22.2% |
Hemiparesis |
11.1% |
Petit Mal Epilepsy |
11.1% |
Restlessness |
11.1% |
Spina Bifida Cystica |
11.1% |
Thrombosis |
11.1% |
Transplant Rejection |
11.1% |
Unintended Pregnancy |
11.1% |
|